Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
6.14
-0.10 (-1.60%)
At close: Apr 28, 2026, 4:00 PM EDT
6.14
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:01 PM EDT
Certara Revenue
In the year 2025, Certara had annual revenue of $418.84M with 8.75% growth. Certara had revenue of $103.65M in the quarter ending December 31, 2025, with 3.28% growth.
Revenue (ttm)
$418.84M
Revenue Growth
+8.75%
P/S Ratio
2.26
Revenue / Employee
$265,760
Employees
1,576
Market Cap
940.65M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.53B |
| Evolent Health | 1.88B |
| Omnicell | 1.18B |
| Claritev | 965.41M |
| GoodRx Holdings | 796.85M |
| Phreesia | 480.59M |
| HealthStream | 304.06M |
| Omada Health | 260.21M |
CERT News
- 6 days ago - Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Benzinga
- 6 days ago - Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat - GlobeNewsWire
- 6 days ago - Veristat to Acquire Certara's Regulatory and Medical Writing Business - Business Wire
- 19 days ago - Certara to Report First Quarter 2026 Financial Results on May 11th, 2026 - GlobeNewsWire
- 7 weeks ago - Certara Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Certara Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Certara Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - GlobeNewsWire